The role of TRH and related peptides in the mechanism of action of ECT

Journal of ECT

Volumn 15, Issue 1, 1999, Pages 76-92

  Sattin, Albert ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Affective disorders; Biogenic amines; Electroconvulsive therapy; Forced swim test; GABA; Glutamate; Limbic system; Neuropeptides; Seizures; Thyrotropin releasing hormone

Indexed keywords

4 AMINOBUTYRIC ACID; ANTIDEPRESSANT AGENT; BIOGENIC AMINE; GLUTAMIC ACID; NEUROPEPTIDE; PROTIRELIN;

AFFECTIVE NEUROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DEPRESSION; ELECTROCONVULSIVE THERAPY; FORCED SWIMMING TEST; FOREBRAIN; GABAERGIC SYSTEM; INTERNEURON; LIMBIC SYSTEM; NONHUMAN; RAT; REMISSION; SEIZURE; SLEEP;

EID: 0032982679     PISSN: 10950680     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124509-199903000-00007     Document Type: Article

References (103)

1. Adinoff B, Nemeroff CB, Bissette G, Martin PR, Linnoila M. Inverse relationship between CSF TRH concentrations and the TSH response to TRH in abstinent alcohol-dependent patients. Am J Psychiatry 1991; 148:1586-8.
2. Amaral DG, Price JL, Pitkanen A, Carmichael ST. Anatomical organization of the primate amygdaloid complex. In: Aggleton JP, ed. The amvgdala: neurobiological aspects of emotion, memory and mental dysfunction. New York: Wiley-Liss, 1992:1-66.
3. Ashworth R, Yu R, Nelson EJ, Dermer S, Gershengorn MC, Hinkle PM. Visualization of the thyrotropin-releasing hormone receptor and its ligand during endocytosis and recycling. Proc Natl Acad Sci USA 1995;92:512-6.
4. Banki CM, Bissette G, Arato M, Nemeroff CB. Elevation of immunoreactive CSF TRH in depressed patients. Am J Psychiatry 1988;145:1526-31.
5. Bench CJ, Frackowiak RS, Dolan RJ. Changes in regional cerebral blood flow on recovery from depression. Psychol Med 1995;25:247-61.
6. Bonne O, Krausz Y. Pathophysiological significance of cerebral perfusion abnormalities in major depression-trait or state marker? Eur Neuropsychopharmacol 1997;7:225-33.
7. Borsini F, Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology 1988;94:147-60.
8. Braun AR, Balkin TJ, Wesensten NJ, Gwadry F, Carson RE, Varga M, Baldwin P, Belenky G, Herskovitch P. Dissociated pattern of activity in visual cortices and their projections during human rapid eye movement sleep. Science 1998;279:91-5.
9. Bulant M, Roussel J-P, Astier H, Nicolas P, Vaudry H. Processing of thyrotropin-releasing hormone prohormone (pro-TRH) generates a biologically active peptide, prepro-TRH-(160-169), which regulates TRH-induced thyrotropin secretion. Proc Natl Acad Sci USA 1990;87:4439-43.
10. Callahan AM, Frye MA, Marangell LB, George MS, Ketter TA, L'Herrou T, Post RM. Comparative antidepressant effects of parenteral and intrathecal thyrotropin releasing hormone: confounding effects of tolerance and implications for therapeutics. Biol Psychiatry 1997;41:264-72.
11. Chizh BA, Headley PM. [TRH]-induced facilitation of spinal neurotransmission: a role for NMDA receptors. Neuropharmacology 1994;33:115-21.
12. Collingridge GL, Coan EJ, Herron CE, Lester RAJ. Role of excitatory amino acid receptors in synaptic transmission and plasticity in hippocampal neurons. In: Hicks TP, Lodge D, McLennan H, eds. Excitatory amino acid transmission. New York: AR Liss, 1987:317-24.
13. Conti F, Rustiono A, Petrusz P, Towle AC. Glutamate-positive neurons in the somatic sensory cortex of rats and monkeys. J Neurosci 1987;7:1887-201.
14. Coplan JD, Andrews MW, Rosenblum LA, Owens MJ, Friedman S, German JM, Nemeroff CB. Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: implications for the pathophysiology of mood and anxiety disorders. Proc Natl Acad Sci USA 1996;93:1619-23.
15. Devanand DP, Sackeim HA, Lo ES, Cooper T, Huttinot G, Prudic J, Ross F. Serial dexamethasone suppression tests and plasma dexamethasone levels. Effects of clinical response to electroconvulsive therapy in major depression. Arch Gen Psychiatry 1991;48:525-33.
16. Devanand DP, Shapira B, Petty F, Kramer G, Fitzsimons L, Lerer B, Sackeim HA. Effects of electroconvulsive therapy on plasma GABA. Convulsive Ther 1995;11:3-13.
17. Dori I, Petrou M, Parnavelas JG. Excitatory transmitter amino acid-containing neurons in the rat visual cortex: a light and electron microscopic immunocytochemical study. J Comp Neurol 1989;290:169-84.
18. Drevets WC, Price JL, Simpson JR Jr, Todd RD, Reich T, Vannier M, Raichle ME. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997;386:824-7.
19. 3im-methyl-TRH. J Clin Endocrinol Metab 1977;44:582-5.
20. Ehrensing RH, Kastin AJ, Schalch DS, Friesen HG, Vargas JR, Schally AV Affective state and thyrotropin-releasing hormone in depressed patients. Am J Psychiatry 1974;131:714-8.
21. Ferraro TN, Golden GT, Hare TA. Repeated ECS selectively alters GABA levels in the rat brain: effects of electrode placement. Convulsive Ther 1990;6:199-208.
22. Fink M, Nemeroff C. A neuroendocrine view of ECT. Convulsive Ther 1989;5:296-304.
23. Friedman TC, Yanovski JA, Jayasvasti V, Yanovski SZ, Koenig RJ, Wilk S. Pyroglutamyl peptidase-II ("thyroliberinase") activity in human serum: influence of weight and thyroid status. J Clin Endocrinol Metab 1995;80:1086-9
24. Gale K. Role of GABA in the genesis of chemoconvulsant seizures. Toxicol Lett 1992a;12:64-65, 417-28.
25. Gale K. GABA and epilepsy: basic concepts from preclinical research. Epilepsia 1992b;33(suppl 5):S3-12.
26. Garbutt JC, Mayo JP, Little KY, Gillette GM, Mason GA, Dew B, Prange AJ Jr. Dose-response studies with protirelin. Arch Gen Psychiatry 1994;51:875-83.
27. Gary KA, Sollars PJ, Winokur A. Sleep and the thyroid axis: alterations in thyrotropin-releasing hormone (TRH) concentrations following 48 hour sleep deprivation in the rat. Neuropsychopharmacology 1996; [Abstr.] p 11 (in annual meeting volume, American College of Neuropsychopharmacology).
28. Gellman RL, Aghajanian GK. Pyramidal cells in piriform cortex receive a convergence of inputs from monoamine activated GABAergic interneurons. Brain Res 1993;600:63-73.
29. B receptor function in mouse frontal cortex after repeated administration of antidepressant drugs or electroconvulsive shocks. Br J Pharmacol 1987;92:357-62.
30. Green AR, Minchin MC, Vincent ND. Inhibition of GABA release from slices prepared from several brain regions of rats at various times following a convulsion. Br J Pharmacol 1987;92:13-8.
31. Green AR, Vincent ND. The effect of repeated electroconvulsive shock on GABA synthesis and release in regions of rat brain. Br J Pharmacol 1987;92:19-24.
32. Hicks TP. Excitatory amino acid pathways in cerebral cortex. In: Hicks TP, Lodge D, McLennan, H, eds. Excitatory amino acid transmission. New York: AR Liss, 1987:373-80.
33. Ho AP, Gillin JC, Buchsbaum MS, Wu JC, Abel L, Bunney WE Jr. Brain glucose metabolism during non-rapid eye movement sleep in major depression. A positron emission tomography study. Arch Gen Psychiatry 1996;53:645-52.
34. Hokfelt T, Tsuruo Y, Ulfhake B, Cullheim S, Arvidsson U, Foster GA, Schultzberg M, Schalling M, Arborelius L, Freedman J, Post C, Visser T. Distribution of TRH-like immunoreactivity with special reference to coexistence with other neuroactive compounds. Ann NYAcad Sci 1989;553:76-105.
35. Hope BT, Kelz MB, Duman RS, Nestler EJ. Chronic electroconvulsive seizure (ECS) treatment results in expression of a long-lasting AP-1 complex in brain with altered composition and characteristics. J Neurosci 1994;14:4318-28.
36. Hornig M, Mozley PD, Amsterdam JD. HMPAO SPECT brain imaging in treatment-resistant depression. Prog Neuropsychopharmacol Biol Psychiatry 1997;21:1097-114.
37. Ito H, Kawashima R, Awata S, Ono S, Sato K, Goto R, Koyama M, Sato M, Fukuda H. Hypoperfusion in the limbic system and prefrontal cortex in depression: SPECT with anatomic standardization technique [see comments]. J Nucl Med 1996;37:410-4.
38. Kastin AJ, Ehrensing RH, Schalch DS, Anderson MS. Improvement in mental depression with decreased thyrotropin response after administration of thyrotropin-releasing hormone. Lancet 1972;2:740-2.
39. Kim S-Y, Post RM, Rosen JB. Differential regulation of basal and kindling-induced TRH mRNA expression by thyroid hormone in the hypothalamic and limbic structures. Neuroendocrinology 1996;63:297-304.
40. Kirkegaard C, Faber J, Hummer L, Rogowski P. Increased levels of TRH in cerebrospinal fluid from patients with endogenous depression. Psychoneuroendocrinology 1979;4:227-35.
41. Knoblach SM, Kubek MJ. TRH release is enhanced in hippocampal slices after electroconvulsive shock. J Neurochem 1994;62:119-25.
42. Knoblach SM, Kubek MJ. Increases in thyrotropin-releasing hormone messenger RNA expression induced by a model of human temporal lobe epilepsy: effect of partial and complete kindling. Neuroscience 1997;76:85-95.
43. Knoblach SM, Kubek MJ. Changes in thyrotropin-releasing hormone levels in hippocampal subregions induced by a model of human temporal lobe epilepsy: effect of partial and complete kindling. Neuroscience 1997;76:97-104.
44. Koenig ML, Yourick DL, Meyerhoff JL. Thyrotropin-releasing hormone (TRH) attenuates glutamate-stimulated increases in calcium in primary neuronal cultures. Brain Res 1996;730:143-9.
45. Kreider MS, Engber TM, Nilaver G, Zimmerman EA, Winokur A. Immunohistochemical localization of TRH in rat CNS: comparison with RIA studies. Peptides 1985;6:997-1000.
46. Kubek MJ, Etchison D, Sattin A. Electroshock (ECS) induced alterations of thyrotropin-releasing hormone (TRH) in the rat. Soc Neurosci Abstr 1981;7:379.
47. Kubek MJ, Knoblach SM, Sharif NA, Burt DR, Buterbaugh GG, Fuson KS. TRH gene expression and receptors are differentially modified in limbic foci by seizures. Ann Neurol 1993;33:70-6.
48. Kubek MJ, Low WC, Sattin A, Morzorati SL, Meyerhoff JL, Larsen SH. Role of TRH in seizure modulation. Ann NY Acad Sci 1989;553:286-303.
49. Kubek MJ, Meyerhoff JL, Hill TG, Norton JA, Sattin A. Effects of subconvulsive and repeated electroconvulsive shock on thyrotropin-releasing hormone in rat brain. Life Sci 1985;36:310-5.
50. Kubek MJ, Sattin A. Effect of electroconvulsive shock on the content of TRH in rat brain. Life Sci 1984;34:1149-52.
51. Kupfer DJ, Frank E, McEachran AB, Grochocinski VJ. Delta sleep ratio. A biological correlate of early recurrence in unipolar affective disorder. Arch Gen Psychiatry 1990;47:1100-05.
52. Ladram A, Bulant M, Montagne JJ, Nicolas P. Distribution of TRH-potentiating peptide (PS4) and its receptors in rat brain and peripheral tissues. Biochem Biophys Res Commun 1994;200:958-65.
53. Lechan RM, Wu P, Jackson IMD, Wolf H, Cooperman S, Mandel G, Goodman RH. TRH precursor: characterization in rat brain. Science 1986;231:159-61.
54. Levav I, Kohn R, Golding JM, Weissman MM. Vulnerability of Jews to affective disorders. Am J Psychiatry 1997;154:941-7.
55. Lexow WC, Phillips J, Dichter M, O'Connor M, Winokur A. Alterations in TRH receptors in discrete regions of the hippocampus in temporal lobe epilepsy. Soc Neurosci Abstr 1990;16:447.
56. Loosen PT, Prange AJ. Serum thyrotropin response to thyrotropin-releasing hormone in psychiatric patients: a review. Am J Psychiatry 1982;139:405-16.
57. Low WC, Farber SD, Hill TG, Zaphiriou MR, Sattin A, Kubek MJ. Evidence for extrinsic and intrinsic sources of thyrotropin-releasing hormone (TRH) in the hippocampal formation as determined by radioimmunoassay and immunocytochemistry. Ann NY Acad Sci 1989;553:574-8.
58. Maquet P, Peters JM, Aerts J, Delfiore G, Degueldre C, Luxen A, Franck G. Functional neuroanatomy of human rapid-eye-movement sleep and dreaming. Nature 1996;383:163-6.
59. Marangell LB, Callahan AM, George MS, Ketter T, Pazzaglia PL, Herrou T, Gabriele S, Leverich GL, Post RM. Effects of intrathecal thyrotropin-releasing hormone (TRH) in refractory depressed patients. Arch Gen Psychiatry 1997;54:214-22.
60. Mayberg HS, Lewis PJ, Regenold W, Wagner HN Jr. Paralimbic hypoperfusion in unipolar depression. J Nucl Med 1994;35:929-34.
61. McGivern RF, Rittenhouse P, Aird F, Van de Kar LD, Redei E. Inhibition of stress-induced neuroendocrine and behavioral responses in the rat by prepro-thyrotropin-releasing hormone 178-199. J Neurosci 1997;17:4886-94.
62. Munsat TL, Taft J, Jackson IMD. Pharmacokinetics of intrathecal thyrotropin-releasing hormone. Neurology 1987;37:597-601.
63. Nie Y, Schoepp DD, Kubek MJ. TRH inhibits glutamate release from hippocampal slices in vitro. Soc Neurosci Abstr 1997;23:2314.
64. Nowak G, Paul IA, Popik P, Young A, Skolnick P. Ca2+ antagonists effect an antidepressant-like adaptation of the NMDA receptor complex. Eur J Pharmacol 1993;247:101-2.
65. Nutt DJP, Cowen PJ, Green AR. Studies on the postictal rise in seizure threshold. Eur J Pharmacol 1981;71:287-95.
66. Ogawa N, Mizuno S, Mori A, Nukina I, Ota Z, Yamamoto M. Potential anti-depressive effects of thyrotropin releasing hormone (TRH) and its analogues. Peptides 1984;5:743-6.
67. Owens MJ, Nemeroff CB. The role of corticotropin-releasing factor in the pathophysiology of affective and anxiety disorders: laboratory and clinical studies. Ciba Found Symp 1993;172:296-308, discussion: 308-16.
68. Parker DC, Pekary AE, Hershman JM. Effect of normal and reversed sleep-wake cycles upon nyctohemeral rhythmicity of plasma thyrotropin: evidence suggestive of an inhibitory influence in sleep. J Clin Endocrinol Metab 1976;43:318-29.
69. Paul IA, Duncan GE, Hong JS, Mueller RA. Iksander N, Breese GR. A comparison of the regional effects of antidepressant drugs and chronic electroconvulsive shock on beta-adrenergic receptors, thyrotropin-releasing hormone- and dynorphin (1-8)-like immunoreactivity in rat brain. Soc Neurosci Abstr 1986;12:416.
70. Paul IA, Duncan GE, Mueller RA, Hong JS, Breese GR. Neural adaptation in response to chronic imipramine and electroconvulsive shock: evidence for separate mechanisms. Eur J Pharmacol 1991;205:135-43.
71. Paul IA, Layer RT, Skolnick P, Nowak, G. Adaptation of the NMDA receptor in rat cortex following chronic electroconvulsive shock or imipramine. Eur J Pharmacol 1993;247:305-11.
72. Paul IA, Nowak G, Layer RT, Popik P, Skolnick P. Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments. J Pharmacol Exp Ther 1994;269:95-102.
73. Pekary AE, Gwirtsman H, Tourtellote WW, Smith VP, Hershman JM. High levels of thyrotropin-releasing hormone precursor peptide immunoreactivity and binding substance occur in human cerebrospinal fluid. Neuroendocrinology 1991;53:246-52.
74. Pekary AE, Lloyd RL, Sattin A. Predominance of pGlu-His-Pro-Gly (TRH-Gly) among all TRH precursor peptides in rat limbic forebrain after electroconvulsive seizures. Ann NY Acad Sci 1994;739:330-3.
75. Pekary AE, Sattin A, Lloyd RL. Electroconvulsive seizures increase levels of PS-4, the TRH-enhancing peptide [prepro-TRH(160-169)], in rat brain. Neuroendocrinology 1997;65:377-84.
76. Petty F. GABA and mood disorders: a brief review and hypothesis. J Affect Disord 1995;34:275-81.
77. Petty F, Kramer GL, Gullion CM, Rush AJ. Low plasma GABA levels in male patients with depression. Biol Psychiatry 1992;32:354-63.
78. Porsolt RD, Anton G, Blavet N, Jalfre M. Behavioral despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 1978;47:379-91.
79. Prange AJ Jr, Wilson IC, Lara PD, Alltop LB, Breese GR. Effects of thyrotropin-releasing hormone in depression. Lancet 1972;2:999-1002.
80. Prudic J, Sackeim HA, Devanand D. Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res 1990;31:287-96.
81. Redding TW, Schally AV Studies on the inactivation of thyrotropin-releasing hormone. Proc Soc Exp Biol Med 1969;131:415-25.
82. Redei E, Hilderbrand H, Aird F. Corticotropin release-inhibiting factor is encoded within prepro-TRH. Endocrinology 1995a;136:1813-6.
83. Redei E, Hilderbrand H, Aird F. Corticotropin release-inhibiting factor is preprothyrotropin-releasing hormone-(178-199). Endocrinology 1995b;136:3557-63.
84. Reichlin S. TRH: historical aspects. Ann NY Acad Sci 1989;553:1-6.
85. Renaud LP, Blume HW, Pittman QJ, Lamour Y, Tan AT. Thyrotropin-releasing hormone selectively depresses glutamate excitation of cerebral cortical neurons. Science 1979;205:1275-7.
86. Roy A, Wolkowitz OM, Bissette G, Nemeroff CB. Differences in CSF concentrations of thyrotropin-releasing hormone in depressed patients and normal subjects: negative findings. Am J Psychiatry 1994; 151:600-2.
87. Sackeim HA, Prudic J, Devanand DP, Decina P, Malitz S. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol 1990;10:96-104.
88. Sattin A. A possible role for thyrotropin-releasing hormone (TRH) in antidepressant treatment. In: Ehrlich YH, Lenox RH, Kornecki E, Berry WO, eds. Molecular mechanisms of neuronal responsiveness. New York: Plenum Press, 1987:549-55.
89. Sattin A, Hill TJ, Meyerhoff, JL, Norton JA, Kubek MJ. The prolonged increase in thyrotropin-releasing hormone in rat limbic forebrain regions following electroconvulsive shock. Regulatory Peptides 1987;19:13-22.
90. Sattin A, Pekary AE, Lloyd RL. TRH gene products are implicated in the antidepressant mechanisms of seizures. Ann NYAcad Sci 1994;739:135-53.
91. Shapiro S, Kubek M, Sanders S, Durbin S, Goodwin S, Javed T. Regional changes in central nervous system thyrotropin-releasing hormone after pentylenetetrazol-induced seizures in dogs. Neurosurgery 1992;31:935-9; discussion: 939.
92. Sharif NA. Adaptive changes in brain and pituitary TRH receptors: effect of lesions, kindling, hormones, drugs. Med Sci Res 1987;15:223-7.
93. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA 1996;93:3908-13.
94. Shi ZX, Levy A, Lightman SL. Hippocampal input to hypothalamus inhibits thyrotropin and thyrotropin-releasing hormone gene expression. Neuroendocrinology 1993;57:576-80.
95. Skolnick P, Miller R, Young A, Boje K, Trullas R. Chronic treatment with 1-aminocyclopropanecarboxylic acid desensitizes behavioral responses to compounds acting at the NMDA receptor complex. Psychopharmacol 1992;107:489-96.
96. Stocca G, Nistri A. Modulation by TRH of NMDA-elicited responses of CA 1 neurons of the rat hippocampal slice preparation. Neurosci Lett 1994;166:139-42.
97. Stone TW. Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev 1993;45:309-79.
98. Szuba MP, Baxter LR Jr, Fairbanks LA, Guze BH, Schwartz JM. Effects of partial sleep deprivation on the diurnal variation of mood and motor activity in major depression. Biol Psychiatry 1991;30:817-29.
99. Tsuruo Y, Hokfelt T, Visser T. Thyrotropin releasing hormone (TRH)-immunoreactive cell groups in the rat central nervous system. Exp Brain Res 1987;68:213-7.
100. Winokur G, Behar D, Vanvalkenburg C, Lowry M. Is a familial definition of depression both feasible and valid? J Nerv Ment Dis 1978;166:764-8.
101. Wright SR, Stewart CA, Naylor P, Reid IC, Pearson RCA. Increased GAD mRNA in the rat dentate gyrus following repeated electroconvulsive shock. Soc Neurosci Abstr 1996;22:236.
102. Wu JC, Bunney WE. The biological basis of an antidepressant response to sleep deprivation and relapse: review and hypothesis [see comments]. Am J Psychiatry 1990;147:14-21.
103. Yang H, Tache Y. Prepro-TRH-(160-169) potentiates gastric acid secretion stimulated by TRH microinjected into the dorsal motor nucleus of the vagus. Neurosci Lett 1994;174:43-6.